
DXLG Stock Forecast & Price Target
DXLG Analyst Ratings
Bulls say
Destination XL Group is showing signs of progress, with total sales in the first quarter just below consensus. While comps were down, they were the best since 2Q23 and the trend did decelerate through the quarter. Various internal initiatives, such as the FITMAP technology and an assortment change strategy, are expected to drive improved margins and sales in the future. However, the pressure from GLP-1 drugs on customer behavior remains a concern. The potential tender offer from Zodiac Partners and the pending merger with FullBeauty could also positively impact the company in the near future.
Bears say
Destination XL Group is facing several challenges that could hinder its financial performance, including the high costs associated with the proposed tender offer from Zodiac Partners. Additionally, the pending merger with FullBeauty Brands may face delays due to the delayed filing of the company's 10-K and proxy statement. The company also faces risks of supply chain disruptions, price sensitivity and inflation, and changing consumer tastes, which may impact its ability to drive sales and maintain margins. With low barriers to entry in the market, competition from new entrants, particularly in the big and tall space, is also a concern. All of these factors contribute to our negative outlook on the company's stock.
This aggregate rating is based on analysts' research of Destination XL Group and is not a guaranteed prediction by Public.com or investment advice.
DXLG Analyst Forecast & Price Prediction
Start investing in DXLG
Order type
Buy in
Order amount
Est. shares
0 shares